Posez n’importe quelle question sur les cours, conférences, exercices, recherches, actualités, etc. de l’EPFL ou essayez les exemples de questions ci-dessous.
AVERTISSEMENT : Le chatbot Graph n'est pas programmé pour fournir des réponses explicites ou catégoriques à vos questions. Il transforme plutôt vos questions en demandes API qui sont distribuées aux différents services informatiques officiellement administrés par l'EPFL. Son but est uniquement de collecter et de recommander des références pertinentes à des contenus que vous pouvez explorer pour vous aider à répondre à vos questions.
Background Disrupted sense of agency (SoA), the perceived loss of control over one’s actions, is common in functional neurological disorder (FND) and linked to abnormal activation in agency-related networks, particularly the right temporoparietal junction (rTPJ). This proof-of-concept study tested whether fMRI neurofeedback (NF) could enhance SoA in FND by targeting the rTPJ. Methods In this single-arm feasibility study, 18 patients with mixed FND symptoms completed three NF trainings during an adaptive visuomotor task, receiving intermittent visual feedback of their rTPJ activity. Pre- and post-training assessments included subjective agency ratings, neuroimaging during a transfer task, and clinical evaluations. Results Group-level subjective agency significantly increased after training ( p = 0.0083), driven by responders (n = 8) who exhibited rTPJ ( p = 0.042) and supplementary motor area (SMA) upregulation ( p = 0.015) in the first session, alongside consistent task engagement. Behavioral gains coincided with trend-level decreases in rTPJ–dorsolateral prefrontal cortex (dlPFC) connectivity ( p = 0.098), while non-responders showed reduced rTPJ–SMA connectivity ( p = 0.008). No group-level clinical improvements were observed, but higher initial rTPJ ( p = 0.03, ρ = –0.78) and dlPFC ( p = 0.03, ρ = –0.75) activation were negatively associated with changes in self-reported core symptoms. Conclusion NF from rTPJ activity is feasible in FND and may enhance explicit SoA in a subset of patients through early neural modulation and sustained engagement. High inter-individual variability underscores the need for sham-controlled trials with optimized, engaging feedback designs and longitudinal monitoring to identify patients who could benefit from NF.